Skip to main content
Have a personal or library account? Click to login
Results of postoperative radiochemotherapy of the patients with resectable gastroesophageal junction adenocarcinoma in Slovenia Cover

Results of postoperative radiochemotherapy of the patients with resectable gastroesophageal junction adenocarcinoma in Slovenia

Radiology and Oncology
Volume 46 (2012): Issue 4 (December 2012)
By: ,  ,  ,  ,   and    
Open Access
|Nov 2012
References

References

  1. 1. Siewert JR, Stein HJ. Classification of adenocarcinoma of the oesophagogastric junction.1998;1457-9.
    Search in Google Scholar
  2. 2. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistic, 2002.2005;74-108.
    Open DOISearch in Google Scholar
  3. 3. American Joint Committee on Cancer. AJCC cancer staging manual, 7th edition. New York: Springer-Verlag; 2009.
    Search in Google Scholar
  4. 4. Wronski M, Ziarkiewicz-Wroblewska B, Slodkowski M, Cebulski W, Gornicka B Krasnodebski IW. Mesenteric fibromatosis with intestinal involvement mimicking a gastrointestinal stromal tumour.2011;59-63.
    Open DOISearch in Google Scholar
  5. 5. Oblak I, Velenik V, Anderluh F, Strojan P. Results of adjuvant radiochemotherapy for gastric adenocarcinoma in Slovenia.2007;982-7.
    Open DOISearch in Google Scholar
  6. 6. Oblak I, Anderluh Franc, Velenik V. Postoperative radiochemotherapy for gastric adenocarcinoma: long term results.2009;274-81.
    Open DOISearch in Google Scholar
  7. 7. Power DG, Reynolds JV. Localized adenocarcinoma of the esophagogastric junction-is there a standard of care?2010;400-9.
    Search in Google Scholar
  8. 8. Wayman J, Bennet MK, Rames SA, Griffin SM. The pattern of recurrence of adenocarcinoma of the oesophagogastric junction.;1223-9.
    Open DOISearch in Google Scholar
  9. 9. Schuhmacher C, Gretschel S, Lordick F, Reichardt P, Hohenberger W, Eisenberger CF, et al. Neoadjuvant chemotherapy compared with surgery alone for locally advanced cancer of the stomach and cardia: European Organisation for Research and Treatment of Cancer randomized trial 40954.2010;5210-8.
    Open DOISearch in Google Scholar
  10. 10. Walsh TN, Noonan N, Hollywood D, Kelly A, Keeling N, Hennessy TP. A comparison of multimodal therapy and surgery for esophageal adenocarcinoma.1996;462-7.
    Open DOISearch in Google Scholar
  11. 11. Tepper J, Krasna MJ, Niedzwiecki D, Hollis D, Reed CE, Goldberg R, et al. Phase III trial of trimodality therapy with cisplatin, fluorouracil, radiotherapy and surgery compared with surgery alone for esophageal cancer: CALGB 9781.2008;1086-92.
    Open DOISearch in Google Scholar
  12. 12. Ajani JA, Rodriguez W, Bodoky G, Moiseyenko V, Lichinitser M, Gorbunova V, et al. Multicenter phase III comparison of cisplatin/S-1 with cisplatin/infusional fluorouracil in advanced gastric or gastroesophageal adenocarcinoma study: the FLAGS trial.2010;1547-53.
    Open DOISearch in Google Scholar
  13. 13. Macdonald JS, Smalley SR, Benedetti J, Hundahl SA, Estes NC, Stemmermann G, et al.. Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction.2001;725-30.
    Open DOISearch in Google Scholar
  14. 14. Kim S, Lim DH, Lee J, Kang WK, MacDonald S, Park CH, et al. An observational study suggesting clinical benefit for adjuvant postoperative chemoradiation in a population of over 500 cases after gastric resection with D2 nodal dissection for adenocarcinoma of the stomach.2005;1279-85.
    Open DOISearch in Google Scholar
  15. 15. Cunningham D, Allum WH, Stenning SP, Thompson JN, Van de Velde CJH, Nicolson M, et al. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer.2006;11-20.
    Open DOISearch in Google Scholar
  16. 16. Ychou M, Boige V, Pignon JP, Conroy T, Bouché O, Lebreton G, et al. Perioperative chemotherapy compared with surgery alone for resectable gastroesophageal adenocarcinoma: an FNCLCC and FFCD multicenter phase III trial.2011;1715-21.
    Open DOISearch in Google Scholar
  17. 17. Stahl M, Walz MK, Stuschke M, Lehmann N, Meyer HJ, Riera-Knorrenschild J, et al. Phase III comparison of preoperative chemotherapy compared with chemoradiotherapy in patients with locally advanced adenocarcinoma of the esophagogastric junction.2009;851-6.
    Open DOISearch in Google Scholar
  18. 18. Gebski V, Burmeister B, Smithers BM, Foo K, Zalcberg J, Simes J; Australasian Gastro-Intestinal Trials Group. Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis.2007;226-34.
    Open DOISearch in Google Scholar
  19. 19. Fok M, Sham JS, Choy D, Cheng SW, Wong J. Postoperative radiotherapy for carcinoma of the esophagus: a prospective, randomized controlled study.1993;138-47.
    Search in Google Scholar
  20. 20. Teniere P, Hay JM, Fingerhut A, Fagniez PL. Postoperative radiation therapy does not increase survival after curative resection for squamous cell carcinoma of the middle and lower esophagus as shown by a multicenter controlled trial. French university association for surgical research.1991;123-30.
    Search in Google Scholar
  21. 21. Sun P, Xiang JB, Chen ZY. Meta-analysis of adjuvant chemotherapy after radical surgery for advanced gastric cancer.2009;23-33.
    Search in Google Scholar
  22. 22. Liu TS, Wang Y, Chen SY, Sun YH. An updated meta-analysis of adjuvant chemotherapy after curative resection for gastric cancer.2008;1208-16.
    Open DOISearch in Google Scholar
  23. 23. Ajani JA, Welch SR, Raber MN, Fiels WS, Krakoff IM. Comprehensive criteria for assessing therapy-induced toxicity.1990;147-59.
    Open DOISearch in Google Scholar
  24. 24. ICRU 50: Prescribing, recording, and reporting photon beam therapy. Bethesda: International Commission on Radiation Units and Measurements Press; 1993.
    Search in Google Scholar
  25. 25. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations.1958;457-81.
    Open DOISearch in Google Scholar
  26. 26. Peto R, Pike MC, Armitage P. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples.1977;1-39.
    Open DOISearch in Google Scholar
  27. 27. Cox DR. Regression models and life-tables.1972;187-220.
    Open DOISearch in Google Scholar
  28. 28. Enzinger PC, Mayer RJ. Esophageal cancer.2003;2241-52.
    Open DOISearch in Google Scholar
  29. 29. Pisani P, Parkin DM, Ferlay J. Estimates of the worldwide mortality from 18 major cancers in 1985.1993;891-903.
    Open DOISearch in Google Scholar
  30. 30. Torrente S, Turri L, Deantonio L, Cena T, Gambaro G, Magnani C, et al. Concomitant chemo-radiotherapy for unresectable oesophageal cancer: A mono-institutional study on 40 patients.2012;226-32.
    Open DOISearch in Google Scholar
  31. 31. Adelstein DJ, Rice TW, Rybicki LA, Saxton JP, Videtic GMM, Murthy SC, et al. Mature results from a phase II trial of postoperative concurrent chemoradiotherapy for poor prognosis cancer of the esophagus and gastroesophageal junction.2009;1264-9.
    Open DOISearch in Google Scholar
  32. 32. Feith M, Stein HJ, Siewert JR. Adenocarcinoma of the esophagogastric junction: surgical therapy based on 1602 consecutive resected patients.2006;751-64.
    Open DOISearch in Google Scholar
  33. 33. Weitz J, Jaques DP, Brennan M, Karpeh M. Association of splenectomy with postoperative complications in patients with proximal gastric and gastroesophageal junction cancer.2004;682-9.
    Open DOISearch in Google Scholar
  34. 34. Pultrum BB, van Bastelaar J, Schreurs MA, van Dullemen HM, Groen H, Nijsten MWN, et al. Impact of splenectomy on surgical outcome in patients with cancer of the distal esophagus and gastro-esophageal junction.2008;334-9.
    Open DOISearch in Google Scholar
  35. 35. Lagarde SM, ten Kate FJ, Reitsma JB, Busch OR, van Lanschot JJ. Prognostic factors in adenocarcinoma of the esophagus or gastroesophageal junction.2006;4347-55.
    Open DOISearch in Google Scholar
  36. 36. Eloubeidi MA, Desmond R, Arguedas MR, Reed CE, Wilcox CM. Prognostic factors for the survival of patients with esophageal carcinoma in the US.2002;1434-43.
    Open DOISearch in Google Scholar
  37. 37. Steup WH, de Leyn P, Deneffe G, van Raemdonck D, Coosemans W, Lerut T. Tumors of the esophagogastric junction. Long-term survival in relation to the pattern of lymph node metastasis and a critical analysis of the accuracy or inaccuracy of pTNM classification.1996;85-94.
    Open DOISearch in Google Scholar
  38. 38. Mariette C, Taillier G, van Seuningen I, Triboulet JP. Factors affecting postoperative course and survival after en bloc resection for esophageal carcinoma.2004;177-83.
    Open DOISearch in Google Scholar
  39. 39. Lerut T, Coosemans W, Decker G, de Leyn P, Moons J, Nafteux P, et al. Extended surgery for cancer of the esophagus and gastroesophageal junction.2004;58-63.
    Open DOISearch in Google Scholar
  40. 40. Predrazzani C, de Manzoni G, Marrelli D, Giacopuzzi S, Corso G, Minicozzi AM, et al. Lymph node involvement in advanced gastroesophageal junction adenocarcinoma.2007;378-85.
    Open DOISearch in Google Scholar
  41. 41. Siewert JR, Feith M, Werner M, Stein HJ. Adenocarcinoma of the esophagogastric junction: results of surgical therapy based on anatomical/topographic classification in 1002 consecutive patients.2000;353-61.
    Open DOISearch in Google Scholar
  42. 42. Crumley ABC, Stuart RC, McKernan M, Going JJ, Shearer CJ, McMilan DC. Comparison of the pre-treatment clinical prognostic factors in patients with gastro-oesophageal cancer and proposal of a new staging system.2010;781-7.
    Open DOISearch in Google Scholar
  43. 43. Deans DAC, Tan BH, Wigmore SJ, Ross JA, de Beaux AC, Paterson-Brown S, et al. The influence of systemic inflammation, dietary intake and stage of disease on rate of weight loss in patients with gastro-oesophageal cancer.2009;63-9.
    Open DOISearch in Google Scholar
  44. 44. Stahl M, Wilke H, Stuschke M, Walz MK, Fink U, Molls M, et al. Clinical response to induction chemotherapy predicts local control and long-term survival in multimodal treatment of patients with locally advanced esophageal cancer.2005;67-72.
    Open DOISearch in Google Scholar
  45. 45. Kelsen DP, Ginsberg R, Pajak TF, Sheahan DB, Gunderson L, Mortimer J, et al. Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer. .1998;1979-84.
    Open DOISearch in Google Scholar
  46. 46. Plaisant N, Senesse P, Azria D, Lemanski C, Ychou M, Quenet F, et al. Surgery for esophageal cancer after concomitant radiochemotherapy: oncologic and functional results.2005;32-8.
    Open DOISearch in Google Scholar
  47. 47. Kovac V, Zwitter M, Zagar T. Improved survival after introduction of chemotherapy for malignant pleural mesothelioma in Slovenia: Population-based survey of 444 patients.2012;136-44.
    Open DOISearch in Google Scholar
  48. 48. Leigh Y, Seagroatt V, Goldacre M, McCulloch P. Impact of socio-economic deprivation on death rates after surgery for upper gastrointestinal tract cancer.2006;940-3.
    Open DOISearch in Google Scholar
  49. 49. Sabel MS, Smith JL, Nava HR, Mollen K, Douglass HO, Gibbs JF. Esophageal resection for carcinoma in patients older than 70 years.2002;210-4.
    Open DOISearch in Google Scholar
  50. 50. McKernan M, McMillan DC, Anderson JR, Angerson WJ, Stuart RC. The relationship between quality of life (EORTC QLQ-C30) and survival in patients with gastro-oesophageal cancer.2008;888-93.
    Open DOISearch in Google Scholar
  51. 51. Sauvanet A, Mariette C, Thomas P, Lozac’h P, Segol P, Tiret E, et al. Mortality and morbidity after resection for adenocarcinoma of the gastroesophageal junction: predictive factors.2005;253-62.
    Open DOISearch in Google Scholar
  52. 52. Cuschieri A, Weeden S, Fielding J, Bancewicz J, Craven J, Joypaul V, et al. Patient survival after D1 and D2 resections for gastric cancer: long-term results of the MRC randomized surgical trial. Surgical Co-operative Group.1999;1522-30.
    Open DOISearch in Google Scholar
  53. 53. Schmid A, Thybusch A, Kremer B, Henne-Bruns D. Differential effects of radical D2-lymphadenectomy and splenectomy in surgically treated gastric cancer patients.2000;579-85.
    Search in Google Scholar
  54. 54. Huang CM, Wang JB, Lu HS, Zheng CH, Li P, Xie JW, et al. Prognostic impact of splenectomy on advanced proximal gastric cancer with more than 10 lymph node metastasis.2009;2757-62.
    Search in Google Scholar
  55. 55. Buyukasik O, Hasdemir AO, Gulnerman Y, Col1 C, Ikiz O. Second primary cancers in patients with gastric cancer.2010;239-43.
    Open DOISearch in Google Scholar
  56. 56. Ikequchi M, Kaibara N. Lymph node metastasis at the splenic hilum in proximal gastric cancer.2004;645-8.
    Open DOISearch in Google Scholar
  57. 57. Kočevar N, Odreman F, Vindigni A, Grazio SF, Komel R. Proteomic analysis of gastric cancer and immunoblot validation of potential biomarkers.2012;1216-28.
    Open DOISearch in Google Scholar
DOI: https://doi.org/10.2478/v10019-012-0049-4 | Journal eISSN: 1581-3207 | Journal ISSN: 1318-2099
Journal RSS Feed
Language: English
Page range: 337 - 345
Submitted on: May 8, 2012
Accepted on: Jul 27, 2012
Published on: Nov 9, 2012
Published by: Association of Radiology and Oncology
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
gastroesophageal junction adenocarcinoma,
postoperative radiochemotherapy,
toxicity
Related subjects:
Medicine,
Clinical medicine,
Radiology

© 2012 Ana Jeromen, Irena Oblak, Franc Anderluh, Vaneja Velenik, Marija Skoblar Vidmar, Ivica Ratoša, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons License.

Volume 46 (2012): Issue 4 (December 2012)
Previous article
Next article